Published in Biomaterials on July 30, 2013
Beyond 3D culture models of cancer. Sci Transl Med (2015) 0.85
Culture models to define key mediators of cancer matrix remodeling. Front Oncol (2014) 0.81
A simple method for organotypic cultures of nervous tissue. J Neurosci Methods (1991) 14.18
Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol (1997) 10.61
The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer (1955) 10.49
Drug penetration in solid tumours. Nat Rev Cancer (2006) 9.80
Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol (2006) 8.81
Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell (2012) 8.71
Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer (2005) 8.70
Modeling tissue morphogenesis and cancer in 3D. Cell (2007) 7.49
The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol (2007) 7.38
Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst (2007) 7.10
Collagen substrata for studies on cell behavior. J Cell Biol (1972) 7.00
Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry (1982) 6.87
Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol (2006) 6.64
How does the extracellular matrix direct gene expression? J Theor Biol (1982) 6.38
Cell and environment interactions in tumor microregions: the multicell spheroid model. Science (1988) 6.02
The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol (2007) 5.81
Solvent compatibility of poly(dimethylsiloxane)-based microfluidic devices. Anal Chem (2003) 5.51
Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol (2005) 5.12
The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour. Br J Cancer (1968) 4.88
Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol (2010) 4.33
Engineering tumors with 3D scaffolds. Nat Methods (2007) 3.96
Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J (2008) 2.82
The role of bioreactors in tissue engineering. Trends Biotechnol (2004) 2.56
Unraveling the microenvironmental influences on the normal mammary gland and breast cancer. Semin Cancer Biol (2008) 2.41
In vivo cultivation of tumor cells in hollow fibers. Life Sci (1995) 2.29
Experimental anti-tumor therapy in 3-D: spheroids--old hat or new challenge? Int J Radiat Biol (2007) 2.12
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance. Proc Natl Acad Sci U S A (2011) 1.97
Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials (2010) 1.95
Role of the extracellular matrix in morphogenesis. Curr Opin Biotechnol (2003) 1.93
Engineering hydrogels as extracellular matrix mimics. Nanomedicine (Lond) (2010) 1.86
Variations in tumor cell growth rates and metabolism with oxygen concentration, glucose concentration, and extracellular pH. J Cell Physiol (1992) 1.77
Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate. Stem Cells (2010) 1.72
Multicellular tumor spheroids: intermediates between monolayer culture and in vivo tumor. Cell Biol Int (1999) 1.63
Quantitative measurement and control of oxygen levels in microfluidic poly(dimethylsiloxane) bioreactors during cell culture. Biomed Microdevices (2007) 1.55
The clinical relevance of cancer cell lines. J Natl Cancer Inst (2013) 1.54
Fibroblast-derived 3D matrix differentially regulates the growth and drug-responsiveness of human cancer cells. Matrix Biol (2008) 1.49
Biomaterials offer cancer research the third dimension. Nat Mater (2010) 1.45
Beyond the Petri dish. Nat Biotechnol (2004) 1.42
3D in vitro bioengineered tumors based on collagen I hydrogels. Biomaterials (2011) 1.26
A dual-fluorescence high-throughput cell line system for probing multidrug resistance. Assay Drug Dev Technol (2009) 1.22
Advancing science and technology via 3D culture on basement membrane matrix. J Cell Physiol (2009) 1.20
Growth and chemotherapeutic response of cells in a hollow-fiber in vitro solid tumor model. J Natl Cancer Inst (1994) 1.14
Soft contact lens polymers: an evolution. Biomaterials (2001) 1.12
Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures. Cancer Res (1985) 1.12
An oxygen-permeable spheroid culture system for the prevention of central hypoxia and necrosis of spheroids. Biomaterials (2012) 1.05
Oxygen transfer in a diffusion-limited hollow fiber bioartificial liver. Artif Organs (2000) 1.04
Enhancing oxygen tension and cellular function in alginate cell encapsulation devices through the use of perfluorocarbons. Biotechnol Bioeng (2007) 1.03
Mass transfer and metabolic reactions in hepatocyte spheroids cultured in rotating wall gas-permeable membrane system. Biomaterials (2007) 1.03
The use of nanoimprinted scaffolds as 3D culture models to facilitate spontaneous tumor cell migration and well-regulated spheroid formation. Biomaterials (2011) 0.99
Hepatocyte function in a hollow fiber bioreactor: a potential bioartificial liver. J Surg Res (1992) 0.97
FEM-based oxygen consumption and cell viability models for avascular pancreatic islets. Theor Biol Med Model (2009) 0.97
A novel formulation of oxygen-carrying matrix enhances liver-specific function of cultured hepatocytes. FASEB J (2006) 0.96
Adipogenesis of human adipose-derived stem cells within three-dimensional hollow fiber-based bioreactors. Tissue Eng Part C Methods (2011) 0.90
Microfabrication of an asymmetric, multi-layered microdevice for controlled release of orally delivered therapeutics. Lab Chip (2008) 0.90
Bioreactors in tissue engineering: scientific challenges and clinical perspectives. Adv Biochem Eng Biotechnol (2009) 0.87
Growth of confined cancer spheroids: a combined experimental and mathematical modelling approach. Integr Biol (Camb) (2013) 0.84
Stable immobilization of rat hepatocytes as hemispheroids onto collagen-conjugated poly-dimethylsiloxane (PDMS) surfaces: importance of direct oxygenation through PDMS for both formation and function. Biotechnol Bioeng (2008) 0.82
Integration of hollow fiber membranes improves nutrient supply in three-dimensional tissue constructs. Acta Biomater (2011) 0.80
Manipulation of 3D Cluster Size and Geometry by Release from 2D Micropatterns. Cell Mol Bioeng (2012) 0.80
The development of a bioreactor to perfuse radially-confined hydrogel constructs: design and characterization of mass transport properties. Biorheology (2009) 0.80
Extended delivery of ophthalmic drugs by silicone hydrogel contact lenses. Biomaterials (2008) 0.78
Spontaneous formation of stably-attached and 3D-organized hepatocyte aggregates on oxygen-permeable polydimethylsiloxane membranes having 3D microstructures. Biomed Microdevices (2010) 0.77
A microarray approach to translational medicine in breast cancer: how representative are cell line models of clinical conditions? Anticancer Res (2007) 0.77
Microfibrillated cellulose sheets coating oxygen-permeable PDMS membranes induce rat hepatocytes 3D aggregation into stably-attached 3D hemispheroids. J Biomater Sci Polym Ed (2010) 0.76
A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science (2006) 15.18
Targeting multidrug resistance in cancer. Nat Rev Drug Discov (2006) 10.55
An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people. Science (2012) 7.94
Spatial proximity of translocation-prone gene loci in human lymphomas. Nat Genet (2003) 3.91
Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell (2004) 3.72
P-glycoprotein: from genomics to mechanism. Oncogene (2003) 3.66
Tissue-specific spatial organization of genomes. Genome Biol (2004) 2.57
Comparing cDNA and oligonucleotide array data: concordance of gene expression across platforms for the NCI-60 cancer cells. Genome Biol (2003) 2.52
Sex-specific fitness effects of nutrient intake on reproduction and lifespan. Curr Biol (2008) 2.32
Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev (2012) 2.31
The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy. Annu Rev Pharmacol Toxicol (2008) 2.26
Mechanisms of multidrug resistance in cancer. Methods Mol Biol (2010) 2.25
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance. Proc Natl Acad Sci U S A (2011) 1.97
Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer. Cancer Res (2007) 1.91
Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics. J Natl Cancer Inst (2010) 1.89
Evaluation of current methods used to analyze the expression profiles of ATP-binding cassette transporters yields an improved drug-discovery database. Mol Cancer Ther (2009) 1.83
Synonymous mutations and ribosome stalling can lead to altered folding pathways and distinct minima. J Mol Biol (2008) 1.80
A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. Biochim Biophys Acta (2009) 1.79
Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer. Cancer Res (2006) 1.64
Silent (synonymous) SNPs: should we care about them? Methods Mol Biol (2009) 1.61
Conservation of relative chromosome positioning in normal and cancer cells. Curr Biol (2002) 1.58
The clinical relevance of cancer cell lines. J Natl Cancer Inst (2013) 1.54
Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells. J Transl Med (2008) 1.54
Collateral sensitivity as a strategy against cancer multidrug resistance. Drug Resist Updat (2012) 1.53
Interpretation of dark-field contrast and particle-size selectivity in grating interferometers. Appl Opt (2011) 1.51
Mislocalization of membrane proteins associated with multidrug resistance in cisplatin-resistant cancer cell lines. Cancer Res (2003) 1.48
The "specific" P-glycoprotein inhibitor Tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2). ACS Chem Neurosci (2010) 1.46
A new strategy for fast radiofrequency CW EPR imaging: direct detection with rapid scan and rotating gradients. J Magn Reson (2007) 1.41
Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanoma. Pigment Cell Melanoma Res (2009) 1.38
Single-trial fMRI shows contralesional activity linked to overt naming errors in chronic aphasic patients. J Cogn Neurosci (2010) 1.38
Is resistance useless? Multidrug resistance and collateral sensitivity. Trends Pharmacol Sci (2009) 1.37
Drug resistance: still a daunting challenge to the successful treatment of AML. Drug Resist Updat (2012) 1.35
Human ABCB6 localizes to both the outer mitochondrial membrane and the plasma membrane. Biochemistry (2007) 1.33
SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolism. Mol Cancer Res (2008) 1.30
Subnanoradian X-ray phase-contrast imaging using a far-field interferometer of nanometric phase gratings. Nat Commun (2013) 1.26
Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis. Proc Natl Acad Sci U S A (2010) 1.25
Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy. Mol Cancer Ther (2004) 1.24
Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery. Nat Rev Drug Discov (2009) 1.22
A dual-fluorescence high-throughput cell line system for probing multidrug resistance. Assay Drug Dev Technol (2009) 1.22
Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters. Mol Cancer Ther (2008) 1.19
Analysis of ATP-binding cassette transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance. Mol Pharmacol (2004) 1.18
Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas. Proc Natl Acad Sci U S A (2006) 1.18
Manganese transport and trafficking: lessons learned from Saccharomyces cerevisiae. Eukaryot Cell (2005) 1.18
Synthesis, activity, and pharmacophore development for isatin-beta-thiosemicarbazones with selective activity toward multidrug-resistant cells. J Med Chem (2009) 1.17
Endocytic recycling compartments altered in cisplatin-resistant cancer cells. Cancer Res (2006) 1.16
Expression microdissection: operator-independent retrieval of cells for molecular profiling. Diagn Mol Pathol (2004) 1.16
The sounds of silence: synonymous mutations affect function. Pharmacogenomics (2007) 1.14
Evidence for dual mode of action of a thiosemicarbazone, NSC73306: a potent substrate of the multidrug resistance linked ABCG2 transporter. Mol Cancer Ther (2007) 1.13
Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system. Mol Pharmacol (2002) 1.13
Principal expression of two mRNA isoforms (ABCB 5alpha and ABCB 5beta ) of the ATP-binding cassette transporter gene ABCB 5 in melanoma cells and melanocytes. Pigment Cell Res (2005) 1.12
The dynamics of drug resistance: a mathematical perspective. Drug Resist Updat (2012) 1.12
Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family. Cancer Res (2012) 1.11
Grazing angle Mach-Zehnder interferometer using reflective phase gratings and a polychromatic, un-collimated light source. Opt Express (2010) 1.10
P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential. Cancer Res (2003) 1.08
Studies with novel Pdr5p substrates demonstrate a strong size dependence for xenobiotic efflux. J Biol Chem (2002) 1.08
The transcription factor Erg regulates expression of histone deacetylase 6 and multiple pathways involved in endothelial cell migration and angiogenesis. Blood (2011) 1.07
Stochastic excitation and Hadamard correlation spectroscopy with bandwidth extension in RF FT-EPR. J Magn Reson (2003) 1.07
Clinical relevance of multidrug resistance gene expression in ovarian serous carcinoma effusions. Mol Pharm (2011) 1.06
Electrochemical immunosensors for detection of cancer protein biomarkers. ACS Nano (2012) 1.05
Identification of compounds selectively killing multidrug-resistant cancer cells. Cancer Res (2009) 1.05
Structure of a multidrug transporter. Nat Biotechnol (2009) 1.04
MDR1 synonymous polymorphisms alter transporter specificity and protein stability in a stable epithelial monolayer. Cancer Res (2013) 1.04
Trafficking and localization of platinum complexes in cisplatin-resistant cell lines monitored by fluorescence-labeled platinum. J Cell Physiol (2005) 1.04
Lysosomal trapping of a radiolabeled substrate of P-glycoprotein as a mechanism for signal amplification in PET. Proc Natl Acad Sci U S A (2011) 1.03
Expression microdissection adapted to commercial laser dissection instruments. Nat Protoc (2011) 1.03
Neural bases of categorization of simple speech and nonspeech sounds. Hum Brain Mapp (2006) 1.02
Tumor-associated endothelial cells display GSTP1 and RARbeta2 promoter methylation in human prostate cancer. J Transl Med (2006) 1.02
Motionless phase stepping in X-ray phase contrast imaging with a compact source. Proc Natl Acad Sci U S A (2013) 1.02
Identification of cytoskeletal [14C]carboplatin-binding proteins reveals reduced expression and disorganization of actin and filamin in cisplatin-resistant cell lines. Mol Pharmacol (2004) 1.01
Advances in the molecular detection of ABC transporters involved in multidrug resistance in cancer. Curr Pharm Biotechnol (2011) 1.01
Sensitive measurement of single-nucleotide polymorphism-induced changes of RNA conformation: application to disease studies. Nucleic Acids Res (2012) 1.00
Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance. Chem Rev (2014) 1.00
N-desmethyl-loperamide is selective for P-glycoprotein among three ATP-binding cassette transporters at the blood-brain barrier. Drug Metab Dispos (2010) 0.98
A novel way to spread drug resistance in tumor cells: functional intercellular transfer of P-glycoprotein (ABCB1). Trends Pharmacol Sci (2005) 0.98
MONICA: a compact, portable dual gamma camera system for mouse whole-body imaging. Nucl Med Biol (2010) 0.97
Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2. Proc Natl Acad Sci U S A (2013) 0.96
Down-regulation of a manganese transporter in the face of metal toxicity. Mol Biol Cell (2009) 0.96
Regulation and expression of the ATP-binding cassette transporter ABCG2 in human embryonic stem cells. Stem Cells (2012) 0.95
Impact of intertumoral heterogeneity on predicting chemotherapy response of BRCA1-deficient mammary tumors. Cancer Res (2012) 0.95
Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma. Clin Cancer Res (2012) 0.94
Minipig and beagle animal model genomes aid species selection in pharmaceutical discovery and development. Toxicol Appl Pharmacol (2013) 0.94
Sex differences in nutrient-dependent reproductive ageing. Aging Cell (2009) 0.94
Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene. Pharmacogenomics (2007) 0.93
MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor. Blood (2013) 0.92
Local adaptation of sex induction in a facultative sexual crustacean: insights from QTL mapping and natural populations of Daphnia magna. Mol Ecol (2013) 0.91
Elemental tomography of cancer-cell spheroids reveals incomplete uptake of both platinum(II) and platinum(IV) complexes. J Am Chem Soc (2007) 0.91
A portable fluorescence camera for testing surgical specimens in the operating room: description and early evaluation. Mol Imaging Biol (2011) 0.91